| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Nuclear Receptor Co-Repressor 2 | 14 | 2020 | 24 | 2.340 |
Why?
|
| Adipocytes | 10 | 2020 | 162 | 1.710 |
Why?
|
| Adipose Tissue | 8 | 2020 | 259 | 1.590 |
Why?
|
| Energy Metabolism | 5 | 2020 | 277 | 1.330 |
Why?
|
| Repressor Proteins | 11 | 2009 | 423 | 1.260 |
Why?
|
| PPAR gamma | 6 | 2010 | 73 | 1.240 |
Why?
|
| Receptors, Thyroid Hormone | 12 | 2015 | 160 | 1.120 |
Why?
|
| Nuclear Proteins | 10 | 2015 | 726 | 0.810 |
Why?
|
| Cell Differentiation | 6 | 2020 | 1525 | 0.790 |
Why?
|
| DNA-Binding Proteins | 8 | 2009 | 1242 | 0.780 |
Why?
|
| Practice Guidelines as Topic | 2 | 2019 | 1047 | 0.740 |
Why?
|
| Laminin | 2 | 2018 | 89 | 0.710 |
Why?
|
| Thyroid Diseases | 2 | 2019 | 105 | 0.640 |
Why?
|
| Thyroxine | 3 | 2019 | 353 | 0.640 |
Why?
|
| Subcutaneous Fat | 2 | 2018 | 22 | 0.630 |
Why?
|
| Adiposity | 2 | 2018 | 76 | 0.620 |
Why?
|
| Thyroid Hormones | 8 | 2019 | 329 | 0.620 |
Why?
|
| Adipose Tissue, Beige | 1 | 2018 | 3 | 0.610 |
Why?
|
| Macrophages | 1 | 2020 | 571 | 0.580 |
Why?
|
| Obesity | 4 | 2020 | 971 | 0.560 |
Why?
|
| Insulin Resistance | 2 | 2018 | 353 | 0.540 |
Why?
|
| Thyroid Nodule | 1 | 2017 | 58 | 0.540 |
Why?
|
| Pregnancy Complications | 1 | 2019 | 345 | 0.530 |
Why?
|
| Dexamethasone | 2 | 2015 | 344 | 0.500 |
Why?
|
| Thyroid Neoplasms | 2 | 2017 | 424 | 0.490 |
Why?
|
| Hypopituitarism | 2 | 2005 | 19 | 0.490 |
Why?
|
| Evidence-Based Medicine | 1 | 2017 | 433 | 0.460 |
Why?
|
| Receptors, Glucocorticoid | 1 | 2015 | 131 | 0.450 |
Why?
|
| Nuclear Receptor Co-Repressor 1 | 10 | 2020 | 23 | 0.420 |
Why?
|
| Gene Silencing | 2 | 2010 | 178 | 0.410 |
Why?
|
| Mice | 25 | 2020 | 11761 | 0.400 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 4 | 2014 | 122 | 0.360 |
Why?
|
| Animals | 31 | 2020 | 27371 | 0.350 |
Why?
|
| Leptin | 1 | 2010 | 102 | 0.340 |
Why?
|
| Weight Gain | 4 | 2019 | 119 | 0.330 |
Why?
|
| Adipose Tissue, White | 4 | 2018 | 23 | 0.330 |
Why?
|
| Organ Specificity | 2 | 2020 | 273 | 0.310 |
Why?
|
| Histone Deacetylases | 2 | 2020 | 70 | 0.300 |
Why?
|
| Insulin | 2 | 2010 | 1146 | 0.300 |
Why?
|
| Receptors, Retinoic Acid | 3 | 2006 | 47 | 0.300 |
Why?
|
| Cardiac Output, Low | 1 | 2007 | 14 | 0.300 |
Why?
|
| Response Elements | 5 | 2007 | 65 | 0.290 |
Why?
|
| Mice, Knockout | 6 | 2020 | 2001 | 0.290 |
Why?
|
| Uncoupling Protein 1 | 2 | 2018 | 38 | 0.290 |
Why?
|
| Hypoxia, Brain | 1 | 2007 | 43 | 0.280 |
Why?
|
| Cardiac Output | 1 | 2007 | 156 | 0.280 |
Why?
|
| Dimerization | 8 | 2007 | 143 | 0.280 |
Why?
|
| Transcription Factor Pit-1 | 1 | 2005 | 6 | 0.260 |
Why?
|
| Pituitary Hormones | 1 | 2005 | 7 | 0.260 |
Why?
|
| Thyroid Hormone Receptors beta | 5 | 2006 | 80 | 0.260 |
Why?
|
| p300-CBP Transcription Factors | 1 | 2005 | 29 | 0.260 |
Why?
|
| Cerebrovascular Circulation | 1 | 2007 | 230 | 0.260 |
Why?
|
| Thyroid Hormone Resistance Syndrome | 5 | 2006 | 117 | 0.250 |
Why?
|
| Transcriptional Activation | 4 | 2007 | 294 | 0.240 |
Why?
|
| Mice, Inbred C57BL | 8 | 2020 | 3218 | 0.240 |
Why?
|
| Transfection | 7 | 2009 | 911 | 0.240 |
Why?
|
| Transcription, Genetic | 3 | 2016 | 1157 | 0.240 |
Why?
|
| Septo-Optic Dysplasia | 1 | 2003 | 6 | 0.230 |
Why?
|
| Ventricular Function, Left | 1 | 2007 | 605 | 0.220 |
Why?
|
| Thyrotropin | 3 | 2019 | 289 | 0.220 |
Why?
|
| Protein Binding | 8 | 2007 | 1488 | 0.210 |
Why?
|
| 3T3-L1 Cells | 3 | 2007 | 34 | 0.200 |
Why?
|
| Luciferases | 3 | 2015 | 128 | 0.200 |
Why?
|
| Retinoid X Receptors | 4 | 2007 | 39 | 0.200 |
Why?
|
| Diet, High-Fat | 3 | 2018 | 118 | 0.200 |
Why?
|
| Glutathione Transferase | 5 | 2009 | 112 | 0.200 |
Why?
|
| Real-Time Polymerase Chain Reaction | 2 | 2019 | 282 | 0.200 |
Why?
|
| Genes, Reporter | 3 | 2015 | 275 | 0.200 |
Why?
|
| Hypothyroidism | 3 | 2013 | 241 | 0.190 |
Why?
|
| Receptor Cross-Talk | 2 | 2015 | 34 | 0.190 |
Why?
|
| Cells, Cultured | 4 | 2020 | 2884 | 0.190 |
Why?
|
| Body Weight | 3 | 2019 | 452 | 0.180 |
Why?
|
| Lab-On-A-Chip Devices | 1 | 2020 | 23 | 0.180 |
Why?
|
| Fibroblasts | 3 | 2015 | 755 | 0.180 |
Why?
|
| Adipose Tissue, Brown | 2 | 2018 | 86 | 0.180 |
Why?
|
| Cell Nucleus | 2 | 2016 | 599 | 0.180 |
Why?
|
| Gene Expression | 3 | 2019 | 1310 | 0.180 |
Why?
|
| Male | 15 | 2020 | 42411 | 0.170 |
Why?
|
| Transcription Factors | 7 | 2015 | 1653 | 0.170 |
Why?
|
| Epidermis | 1 | 2020 | 102 | 0.170 |
Why?
|
| Protein Structure, Tertiary | 6 | 2007 | 740 | 0.170 |
Why?
|
| Homeodomain Proteins | 1 | 2003 | 556 | 0.170 |
Why?
|
| Gene Expression Regulation | 5 | 2015 | 1976 | 0.160 |
Why?
|
| Mutagenesis, Site-Directed | 5 | 2009 | 283 | 0.160 |
Why?
|
| Triglycerides | 3 | 2019 | 232 | 0.160 |
Why?
|
| Programmed Cell Death 1 Receptor | 1 | 2020 | 171 | 0.160 |
Why?
|
| Phenotype | 3 | 2020 | 2440 | 0.160 |
Why?
|
| Saccharomyces cerevisiae Proteins | 1 | 2001 | 285 | 0.160 |
Why?
|
| Protein Isoforms | 4 | 2007 | 275 | 0.160 |
Why?
|
| Homeostasis | 1 | 2020 | 417 | 0.150 |
Why?
|
| Lipolysis | 2 | 2015 | 23 | 0.150 |
Why?
|
| Postpartum Period | 1 | 2019 | 144 | 0.150 |
Why?
|
| Organ Culture Techniques | 1 | 2018 | 135 | 0.150 |
Why?
|
| Reference Values | 1 | 2019 | 661 | 0.150 |
Why?
|
| Adult Stem Cells | 1 | 2018 | 29 | 0.150 |
Why?
|
| Models, Molecular | 3 | 2007 | 1303 | 0.150 |
Why?
|
| Microfluidics | 1 | 2018 | 52 | 0.150 |
Why?
|
| Energy Intake | 1 | 2018 | 97 | 0.150 |
Why?
|
| Basement Membrane | 1 | 2018 | 55 | 0.150 |
Why?
|
| Cold Temperature | 1 | 2018 | 160 | 0.150 |
Why?
|
| Recombinant Fusion Proteins | 4 | 2005 | 565 | 0.140 |
Why?
|
| Gene Expression Regulation, Developmental | 2 | 2020 | 661 | 0.140 |
Why?
|
| Cell Line | 7 | 2006 | 2496 | 0.140 |
Why?
|
| Neoadjuvant Therapy | 1 | 2020 | 377 | 0.140 |
Why?
|
| Circadian Rhythm | 1 | 2019 | 305 | 0.140 |
Why?
|
| Thiazolidinediones | 2 | 2009 | 73 | 0.140 |
Why?
|
| Humans | 26 | 2020 | 89357 | 0.140 |
Why?
|
| Mutant Proteins | 2 | 2007 | 96 | 0.140 |
Why?
|
| Executive Function | 1 | 2017 | 91 | 0.130 |
Why?
|
| Thymocytes | 1 | 2016 | 31 | 0.130 |
Why?
|
| Pregnancy | 3 | 2019 | 3018 | 0.130 |
Why?
|
| Stress, Physiological | 1 | 2018 | 232 | 0.130 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 1 | 2016 | 108 | 0.130 |
Why?
|
| Radiation Injuries | 1 | 2017 | 162 | 0.130 |
Why?
|
| Epididymis | 1 | 2015 | 19 | 0.130 |
Why?
|
| Phosphatidate Phosphatase | 1 | 2015 | 9 | 0.130 |
Why?
|
| Promoter Regions, Genetic | 3 | 2007 | 956 | 0.130 |
Why?
|
| Point Mutation | 3 | 2005 | 245 | 0.130 |
Why?
|
| Cognition Disorders | 1 | 2017 | 235 | 0.120 |
Why?
|
| Primary Cell Culture | 1 | 2015 | 76 | 0.120 |
Why?
|
| Memory | 1 | 2017 | 220 | 0.120 |
Why?
|
| Binding Sites | 6 | 2006 | 1117 | 0.120 |
Why?
|
| Amino Acid Sequence | 7 | 2006 | 2062 | 0.120 |
Why?
|
| Chorionic Gonadotropin | 1 | 2014 | 72 | 0.120 |
Why?
|
| Adenomatous Polyposis Coli | 1 | 2014 | 39 | 0.120 |
Why?
|
| Ligands | 6 | 2007 | 445 | 0.120 |
Why?
|
| Mice, Transgenic | 5 | 2010 | 1574 | 0.120 |
Why?
|
| Antibodies, Monoclonal, Humanized | 1 | 2020 | 969 | 0.120 |
Why?
|
| Molecular Sequence Data | 7 | 2006 | 3027 | 0.110 |
Why?
|
| Gene Expression Profiling | 1 | 2019 | 1431 | 0.110 |
Why?
|
| Endocrine System | 1 | 2013 | 17 | 0.110 |
Why?
|
| Protein Transport | 1 | 2015 | 421 | 0.110 |
Why?
|
| Mutation | 7 | 2020 | 4143 | 0.110 |
Why?
|
| Growth Hormone | 1 | 2013 | 96 | 0.110 |
Why?
|
| Thyroid Dysgenesis | 1 | 2013 | 9 | 0.110 |
Why?
|
| Carcinoma, Papillary | 1 | 2014 | 159 | 0.110 |
Why?
|
| Paired Box Transcription Factors | 1 | 2013 | 52 | 0.110 |
Why?
|
| Abortion, Spontaneous | 1 | 2013 | 66 | 0.110 |
Why?
|
| Female | 14 | 2020 | 46202 | 0.110 |
Why?
|
| Attention | 1 | 2017 | 395 | 0.100 |
Why?
|
| Congenital Hypothyroidism | 1 | 2013 | 79 | 0.100 |
Why?
|
| Epithelial Cells | 1 | 2016 | 689 | 0.100 |
Why?
|
| AIDS Dementia Complex | 1 | 2011 | 8 | 0.100 |
Why?
|
| Signal Transduction | 4 | 2016 | 3385 | 0.100 |
Why?
|
| HIV | 1 | 2011 | 48 | 0.090 |
Why?
|
| Plasmids | 2 | 2009 | 291 | 0.090 |
Why?
|
| Corpus Callosum | 1 | 2011 | 59 | 0.090 |
Why?
|
| Pituitary Gland | 2 | 2013 | 119 | 0.090 |
Why?
|
| Biomarkers | 2 | 2014 | 1767 | 0.090 |
Why?
|
| Antiretroviral Therapy, Highly Active | 1 | 2011 | 73 | 0.090 |
Why?
|
| Peroxisome Proliferator-Activated Receptors | 1 | 2010 | 7 | 0.090 |
Why?
|
| Mitogen-Activated Protein Kinase 7 | 1 | 2010 | 22 | 0.090 |
Why?
|
| Neuroimaging | 1 | 2011 | 117 | 0.090 |
Why?
|
| Serpins | 1 | 2010 | 31 | 0.090 |
Why?
|
| Glycogen | 1 | 2010 | 59 | 0.090 |
Why?
|
| Nerve Growth Factors | 1 | 2010 | 63 | 0.090 |
Why?
|
| Base Sequence | 4 | 2006 | 2327 | 0.080 |
Why?
|
| Neovascularization, Physiologic | 1 | 2010 | 143 | 0.080 |
Why?
|
| MAP Kinase Signaling System | 1 | 2010 | 198 | 0.080 |
Why?
|
| Electrophoretic Mobility Shift Assay | 2 | 2006 | 73 | 0.080 |
Why?
|
| 3T3 Cells | 1 | 2009 | 97 | 0.080 |
Why?
|
| Consensus Sequence | 3 | 2006 | 65 | 0.080 |
Why?
|
| Heterozygote | 1 | 2010 | 373 | 0.080 |
Why?
|
| Eye Proteins | 1 | 2010 | 128 | 0.080 |
Why?
|
| Anti-HIV Agents | 1 | 2011 | 159 | 0.080 |
Why?
|
| Blotting, Western | 2 | 2019 | 794 | 0.080 |
Why?
|
| DNA Primers | 1 | 2009 | 543 | 0.080 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2014 | 1365 | 0.080 |
Why?
|
| Cloning, Molecular | 1 | 2009 | 646 | 0.080 |
Why?
|
| Amino Acid Substitution | 1 | 2009 | 338 | 0.070 |
Why?
|
| Heart Failure | 1 | 2017 | 1185 | 0.070 |
Why?
|
| Renin | 1 | 2007 | 67 | 0.070 |
Why?
|
| Angiogenesis Inhibitors | 1 | 2010 | 317 | 0.070 |
Why?
|
| Adult | 6 | 2019 | 26607 | 0.070 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2011 | 3448 | 0.070 |
Why?
|
| Retinoic Acid Receptor alpha | 1 | 2006 | 18 | 0.070 |
Why?
|
| Endothelial Cells | 1 | 2010 | 460 | 0.070 |
Why?
|
| Xenopus Proteins | 1 | 2006 | 35 | 0.070 |
Why?
|
| Cyclic AMP | 1 | 2007 | 274 | 0.070 |
Why?
|
| Thyroid Gland | 3 | 2005 | 280 | 0.070 |
Why?
|
| Calcitriol | 1 | 2007 | 173 | 0.070 |
Why?
|
| Postoperative Complications | 1 | 2017 | 2284 | 0.070 |
Why?
|
| Echocardiography, Doppler | 1 | 2007 | 186 | 0.070 |
Why?
|
| Gonadotropin-Releasing Hormone | 1 | 2006 | 108 | 0.070 |
Why?
|
| Frameshift Mutation | 1 | 2006 | 51 | 0.070 |
Why?
|
| Breast Neoplasms | 1 | 2020 | 3011 | 0.070 |
Why?
|
| Lipids | 2 | 2019 | 271 | 0.060 |
Why?
|
| Severity of Illness Index | 2 | 2011 | 1840 | 0.060 |
Why?
|
| DNA | 4 | 2007 | 1308 | 0.060 |
Why?
|
| Hypercholesterolemia | 1 | 2005 | 159 | 0.060 |
Why?
|
| Prognosis | 2 | 2014 | 3783 | 0.060 |
Why?
|
| Transcription Factor HES-1 | 1 | 2003 | 7 | 0.060 |
Why?
|
| RNA Interference | 1 | 2005 | 376 | 0.060 |
Why?
|
| Models, Biological | 3 | 2018 | 1765 | 0.050 |
Why?
|
| Protein Conformation | 1 | 2005 | 889 | 0.050 |
Why?
|
| Age Factors | 1 | 2007 | 1870 | 0.050 |
Why?
|
| Hypoglycemic Agents | 1 | 2005 | 349 | 0.050 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2003 | 172 | 0.050 |
Why?
|
| HIV Infections | 1 | 2011 | 840 | 0.050 |
Why?
|
| Cholesterol | 2 | 2019 | 359 | 0.050 |
Why?
|
| Central Nervous System Diseases | 1 | 2002 | 52 | 0.050 |
Why?
|
| Cross-Sectional Studies | 1 | 2007 | 1714 | 0.050 |
Why?
|
| Risk Factors | 2 | 2013 | 5499 | 0.050 |
Why?
|
| Prevalence | 2 | 2017 | 1243 | 0.050 |
Why?
|
| Adipogenesis | 1 | 2020 | 39 | 0.050 |
Why?
|
| Recombinant Proteins | 2 | 2003 | 1012 | 0.050 |
Why?
|
| Middle Aged | 4 | 2019 | 25974 | 0.050 |
Why?
|
| Fungal Proteins | 1 | 2001 | 141 | 0.050 |
Why?
|
| Heart | 1 | 2003 | 574 | 0.040 |
Why?
|
| Structure-Activity Relationship | 1 | 2001 | 413 | 0.040 |
Why?
|
| Genes, Lethal | 1 | 2020 | 53 | 0.040 |
Why?
|
| Transcription Factor RelA | 1 | 2020 | 49 | 0.040 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2009 | 1176 | 0.040 |
Why?
|
| Protein Interaction Domains and Motifs | 1 | 2020 | 86 | 0.040 |
Why?
|
| NF-kappa B | 2 | 2016 | 466 | 0.040 |
Why?
|
| Nuclear Receptor Coactivator 1 | 3 | 2006 | 24 | 0.040 |
Why?
|
| Embryo, Mammalian | 1 | 2020 | 221 | 0.040 |
Why?
|
| Kruppel-Like Transcription Factors | 1 | 2020 | 100 | 0.040 |
Why?
|
| Histone Acetyltransferases | 3 | 2006 | 42 | 0.040 |
Why?
|
| Reference Standards | 1 | 2019 | 144 | 0.040 |
Why?
|
| Liver | 2 | 2019 | 1208 | 0.040 |
Why?
|
| Glucose Tolerance Test | 1 | 2019 | 227 | 0.040 |
Why?
|
| Gene Deletion | 1 | 2020 | 342 | 0.040 |
Why?
|
| Electrophoresis | 1 | 1998 | 55 | 0.040 |
Why?
|
| Prospective Studies | 1 | 2007 | 4289 | 0.040 |
Why?
|
| Echocardiography | 2 | 2019 | 938 | 0.040 |
Why?
|
| Escherichia coli | 1 | 2001 | 605 | 0.040 |
Why?
|
| Glycerol | 1 | 2018 | 35 | 0.040 |
Why?
|
| Sequence Deletion | 1 | 1998 | 205 | 0.040 |
Why?
|
| Neurons | 1 | 2006 | 1584 | 0.040 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 1998 | 418 | 0.040 |
Why?
|
| Pedigree | 2 | 2013 | 970 | 0.040 |
Why?
|
| Trans-Activators | 1 | 2000 | 443 | 0.040 |
Why?
|
| Obesity, Morbid | 1 | 2019 | 233 | 0.030 |
Why?
|
| Histone Deacetylase 2 | 1 | 2016 | 8 | 0.030 |
Why?
|
| Histone Deacetylase 1 | 1 | 2016 | 15 | 0.030 |
Why?
|
| Adiponectin | 1 | 2016 | 20 | 0.030 |
Why?
|
| Aged, 80 and over | 1 | 2007 | 6811 | 0.030 |
Why?
|
| Co-Repressor Proteins | 1 | 2016 | 24 | 0.030 |
Why?
|
| Aged | 2 | 2017 | 19165 | 0.030 |
Why?
|
| Glucose Intolerance | 1 | 2016 | 94 | 0.030 |
Why?
|
| Receptors, Notch | 1 | 2016 | 123 | 0.030 |
Why?
|
| Lipogenesis | 1 | 2014 | 23 | 0.030 |
Why?
|
| Cell Size | 1 | 2014 | 69 | 0.030 |
Why?
|
| Young Adult | 2 | 2019 | 6312 | 0.030 |
Why?
|
| Neoplasm Staging | 1 | 2020 | 2018 | 0.030 |
Why?
|
| Health Status | 1 | 2016 | 371 | 0.030 |
Why?
|
| Sex Factors | 1 | 2017 | 1066 | 0.030 |
Why?
|
| Abortion, Habitual | 1 | 2013 | 33 | 0.030 |
Why?
|
| Infant, Newborn | 2 | 2013 | 2486 | 0.030 |
Why?
|
| Live Birth | 1 | 2013 | 17 | 0.030 |
Why?
|
| Immune Tolerance | 1 | 2016 | 339 | 0.030 |
Why?
|
| Asymptomatic Diseases | 1 | 2013 | 45 | 0.030 |
Why?
|
| PAX8 Transcription Factor | 1 | 2013 | 23 | 0.030 |
Why?
|
| Hormone Replacement Therapy | 1 | 2013 | 85 | 0.030 |
Why?
|
| Chi-Square Distribution | 1 | 2013 | 360 | 0.030 |
Why?
|
| Insulin-Secreting Cells | 1 | 2016 | 404 | 0.030 |
Why?
|
| Gestational Age | 1 | 2013 | 329 | 0.030 |
Why?
|
| Lipid Metabolism | 1 | 2013 | 199 | 0.030 |
Why?
|
| Child | 3 | 2013 | 7174 | 0.020 |
Why?
|
| Feeding Behavior | 1 | 2014 | 327 | 0.020 |
Why?
|
| CD4 Lymphocyte Count | 1 | 2011 | 67 | 0.020 |
Why?
|
| Academic Medical Centers | 1 | 2013 | 385 | 0.020 |
Why?
|
| Viral Load | 1 | 2011 | 145 | 0.020 |
Why?
|
| Phosphoenolpyruvate Carboxykinase (ATP) | 1 | 2010 | 3 | 0.020 |
Why?
|
| Calorimetry, Indirect | 1 | 2010 | 14 | 0.020 |
Why?
|
| MAP Kinase Kinase 5 | 1 | 2010 | 12 | 0.020 |
Why?
|
| Fatty Acids, Nonesterified | 1 | 2010 | 68 | 0.020 |
Why?
|
| Specific Pathogen-Free Organisms | 1 | 2010 | 78 | 0.020 |
Why?
|
| Diagnosis, Differential | 1 | 2014 | 1597 | 0.020 |
Why?
|
| RNA, Viral | 1 | 2011 | 317 | 0.020 |
Why?
|
| Lactic Acid | 1 | 2010 | 92 | 0.020 |
Why?
|
| Linear Models | 1 | 2011 | 421 | 0.020 |
Why?
|
| Triiodothyronine | 2 | 2003 | 344 | 0.020 |
Why?
|
| Aging | 1 | 2014 | 718 | 0.020 |
Why?
|
| Fasting | 1 | 2010 | 163 | 0.020 |
Why?
|
| Chicago | 1 | 2013 | 1427 | 0.020 |
Why?
|
| Enzyme Activation | 1 | 2010 | 698 | 0.020 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2011 | 445 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2010 | 887 | 0.020 |
Why?
|
| Mice, Nude | 1 | 2010 | 815 | 0.020 |
Why?
|
| Longitudinal Studies | 1 | 2011 | 1072 | 0.020 |
Why?
|
| Phosphorylation | 1 | 2010 | 1132 | 0.020 |
Why?
|
| Otx Transcription Factors | 1 | 2006 | 3 | 0.020 |
Why?
|
| Myelin Basic Protein | 1 | 1986 | 50 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2013 | 2872 | 0.020 |
Why?
|
| Cognition | 1 | 2011 | 580 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2011 | 1862 | 0.020 |
Why?
|
| Encephalomyelitis, Autoimmune, Experimental | 1 | 1986 | 61 | 0.020 |
Why?
|
| Transgenes | 1 | 2006 | 185 | 0.020 |
Why?
|
| Cholesterol 7-alpha-Hydroxylase | 1 | 2005 | 2 | 0.020 |
Why?
|
| Liver X Receptors | 1 | 2005 | 12 | 0.020 |
Why?
|
| Orphan Nuclear Receptors | 1 | 2005 | 14 | 0.020 |
Why?
|
| RNA | 1 | 2010 | 580 | 0.020 |
Why?
|
| Child, Preschool | 1 | 2013 | 3731 | 0.020 |
Why?
|
| Mice, Mutant Strains | 1 | 2005 | 231 | 0.020 |
Why?
|
| Gene Targeting | 1 | 2005 | 73 | 0.020 |
Why?
|
| Ovary | 1 | 2006 | 261 | 0.020 |
Why?
|
| Hypothalamo-Hypophyseal System | 1 | 2005 | 81 | 0.020 |
Why?
|
| Acyl-CoA Oxidase | 1 | 2004 | 4 | 0.020 |
Why?
|
| Phosphoenolpyruvate Carboxykinase (GTP) | 1 | 2004 | 8 | 0.020 |
Why?
|
| Spinal Cord | 1 | 1986 | 255 | 0.020 |
Why?
|
| COS Cells | 1 | 2004 | 167 | 0.020 |
Why?
|
| Chromatin | 1 | 2007 | 397 | 0.010 |
Why?
|
| Family Health | 1 | 2004 | 162 | 0.010 |
Why?
|
| Mutagenesis | 1 | 2004 | 202 | 0.010 |
Why?
|
| Autoimmune Diseases | 1 | 1986 | 249 | 0.010 |
Why?
|
| Propylthiouracil | 1 | 2003 | 27 | 0.010 |
Why?
|
| Genes, erbA | 1 | 2003 | 10 | 0.010 |
Why?
|
| Iodide Peroxidase | 1 | 2005 | 205 | 0.010 |
Why?
|
| Mice, Inbred Strains | 1 | 2003 | 308 | 0.010 |
Why?
|
| Nucleic Acid Conformation | 1 | 2004 | 342 | 0.010 |
Why?
|
| Apoptosis | 1 | 2010 | 1717 | 0.010 |
Why?
|
| Homozygote | 1 | 2003 | 204 | 0.010 |
Why?
|
| Amino Acid Motifs | 1 | 2003 | 116 | 0.010 |
Why?
|
| Thyroid Nuclear Factor 1 | 1 | 2002 | 12 | 0.010 |
Why?
|
| Models, Genetic | 1 | 2007 | 945 | 0.010 |
Why?
|
| Microscopy, Fluorescence | 1 | 2003 | 428 | 0.010 |
Why?
|
| Recombination, Genetic | 1 | 2003 | 445 | 0.010 |
Why?
|
| Cerebellar Diseases | 1 | 2001 | 21 | 0.010 |
Why?
|
| Syndrome | 1 | 2002 | 449 | 0.010 |
Why?
|
| Germ-Line Mutation | 1 | 2003 | 344 | 0.010 |
Why?
|
| Pituitary-Adrenal System | 1 | 2001 | 64 | 0.010 |
Why?
|
| Hypothalamus | 1 | 2001 | 79 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2013 | 8241 | 0.010 |
Why?
|
| RNA, Messenger | 1 | 2006 | 2017 | 0.010 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2004 | 394 | 0.010 |
Why?
|
| DNA Mutational Analysis | 1 | 2002 | 529 | 0.010 |
Why?
|
| Hemodynamics | 1 | 2003 | 731 | 0.010 |
Why?
|
| T-Lymphocytes | 1 | 1986 | 1224 | 0.010 |
Why?
|
| Alleles | 1 | 2003 | 1135 | 0.010 |
Why?
|
| Lung Diseases | 1 | 2002 | 269 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2003 | 1799 | 0.010 |
Why?
|
| Cell Line, Tumor | 1 | 2004 | 2558 | 0.010 |
Why?
|
| Receptors, Steroid | 1 | 1998 | 42 | 0.010 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 1998 | 269 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2005 | 2366 | 0.010 |
Why?
|
| Liver Neoplasms | 1 | 2004 | 758 | 0.010 |
Why?
|
| Brain | 1 | 2006 | 2285 | 0.010 |
Why?
|
| Time Factors | 1 | 2003 | 5338 | 0.010 |
Why?
|
| Antigens, Surface | 1 | 1986 | 103 | 0.000 |
Why?
|
| Antigens, Differentiation, T-Lymphocyte | 1 | 1986 | 97 | 0.000 |
Why?
|
| Immunity, Cellular | 1 | 1986 | 178 | 0.000 |
Why?
|
| Lymphocyte Activation | 1 | 1986 | 751 | 0.000 |
Why?
|